Dominantly inherited β thalassaemia intermedia caused by a new single nucleotide deletion in exon 2 of the β globin gene: Hb morgantown (β91 CTG>CG)

Journal of Clinical Pathology

Volumn 58, Issue 10, 2005, Pages 1110-1112

  Luo, H Y ^a   Tang, W ^b,d   Eung, S H ^a   Coad, J E ^b   Canfield, P ^b   Keller, F ^c   Crowell Jr , E H ^b   Steinberg, M H ^a   Chui, D H K ^a,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN;

ANEMIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BETA THALASSEMIA; CASE REPORT; EXON; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GLOBIN GENE; HUMAN; MICROCYTIC ANEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL;

ADULT; ANEMIA; BASE SEQUENCE; BETA-THALASSEMIA; CHILD, PRESCHOOL; FEMALE; FRAMESHIFT MUTATION; GENES, DOMINANT; GLOBINS; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA;

EID: 26244457462     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.023010     Document Type: Article

References (13)

1. Olivieri NF. The β-thalassemias. N Engl J Med 1999;341:99-109.
2. Thein SL. Dominant β thalassaemia: molecular basis and pathophysiology. Br J Haematol 1992;80:273-7.
3. Thein SL. Is it dominantly inherited β thalassaemia or just a β-chain variant that is highly unstable? Br J Haematol 1999;107:12-21.
4. Stamatoyannopoulos G, Woodson R, Papayannopoulou T, et al. Inclusion-body β-thalassemia trait. A form of β thalassemia producing clinical manifestations in simple heterozygotes. N Engl J Med 1974;290:939-43.
5. Thein SL, Hesketh C, Taylor P, et al. Molecular basis for dominantly inherited inclusion body β-thalassemia. Proc Natl Acad Sci U S A 1990;87:3924-8.
6. Luo HY, Adewoye AH, Eung SH, et al. A novel sickle hemoglobin: hemoglobin S-South End. J Pediatr Hematol Oncol 2004;26:773-6.
7. Wang W, Ma ES, Chan AY, et al. Single-tube multiplex-PCR screen for anti-3.7 and anti-4.2 α-globin gene triplications. Clin Chem 2003;49:1679-82.
8. Garner C, Tatu T, Reittie JE, et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000;95:342-6.
9. Ristaldi MS, Pirastu M, Murru S, et al. A spontaneous mutation produced a novel elongated β-globin chain structural variant (Hb Agnana) with a thalassemia-like phenotype [letter]. Blood 1990;75:1378-9.
10. Thein SL. Structural variants with a β-thalassemia phenotype. In: Steinberg MH, Forget BG, Higgs DR, et al. Disorders of hemoglobin genetics, pathophysiology, and clinical management. Cambridge: Cambridge University Press, 2001:342-55.
11. Ho PJ, Wickramasinghe SN, Rees DC, et al. Erythroblastic inclusions in dominantly inherited β thalassemias. Blood 1997;89:322-8.
12. Vetter B, Neu-Yilik G, Kohne E, et al. Dominant β-thalassaemia: a highly unstable haemoglobin is caused by a novel 6 bp deletion of the β-globin gene. Br J Haematol 2000;108:176-81.
13. Schechter AN, Gladwin MT. Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med 2003;348:1483-5.